Penn is staring down a nearly 7% drop in federal funding for fiscal 2025, pulling in roughly $948 million, and that shortfall is already reshaping hiring, admissions and capital plans across campus. The reduction has hit research programs hardest and pushed administrators into quick rounds of budget trimming and program reviews. Some graduate cohorts have been shrunk, and laboratory groups are operating with tighter support as the university waits to see where federal policy and legal rulings finally land.
DP analysis: how the money shifted
According to The Daily Pennsylvanian, federal disbursements to Penn fell from about $1.02 billion in FY 2024 to $948 million in FY 2025, based on U.S. Treasury data. The DP’s breakdown shows that assistance sub-awards tumbled about 49%, while prime assistance made up roughly 92% of the total and prime contract awards represented only about 1.5% of Penn’s federal receipts. Penn warned in a campus message that the NIH indirect-cost changes could shave roughly $240 million from its research funding, per the University of Pennsylvania Almanac.
NIH policy and the court fight
In February 2025, the National Institutes of Health issued Notice Number NOT-OD-25-068, which proposed a standardized 15% indirect-cost rate for many grants and would have reduced overhead reimbursements to research institutions. The notice is posted on the National Institutes of Health grants site. Plaintiffs challenged the guidance in court, and a federal district court enjoined implementation. The U.S. Court of Appeals for the First Circuit affirmed that judgment on January 5, 2026, leaving the cap unenforceable while litigation proceeds, per the U.S. Court of Appeals for the First Circuit. That legal back-and-forth, along with the prospect of other agency or budget moves, is one reason university leaders say federal totals have swung from year to year.
How Penn is bracing
Administrators have instituted a hiring freeze and asked schools and centers to find roughly 4% in expenditure reductions, measures first reported by The Daily Pennsylvanian. The university’s Office of Research Services told the DP that “Penn’s research funding remains close to $1 billion,” and officials say much of the year-to-year variation reflects the timing and multi-year nature of federal grants. University leaders describe the cutbacks as defensive moves meant to preserve core research capacity while policy debates and court rulings continue to unfold.
What it means for Philly labs and students
Penn’s FY 2025 Annual Financial Report shows sponsored-program revenue from governmental sources totaled about $1.112 billion, a reminder of how central federal awards are to campus labs and clinical research. That sheer scale helps explain why even modest federal shifts can ripple through hiring, graduate admissions and partnerships with local research organizations. For students and postdocs, the fallout has already included smaller incoming Ph.D. cohorts in some programs and tougher funding decisions within individual labs.
What to watch next
In the coming months, agency guidance and federal budget proposals will be the key tea leaves. Renewed moves by NIH, NSF or other major funders would show up quickly in Penn’s grant tallies. University officials say they will continue to model different funding scenarios and update the Penn community as federal decisions and court developments play out.
